Qiagen NV reported $311.35M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Akebia Therapeutics USD 18.7M 5.68M Sep/2026
argenx SE USD 371M 102.53M Jun/2026
Avita Medical AUD 5.29M 1.64M Jun/2026
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Moderna USD 313M 33M Sep/2026
Organon & Co USD 1.36B 4M Sep/2026
Qiagen NV USD 311.35M 1.75M Jun/2026
Revvity USD 388.85M 10.35M Sep/2026
Viatris USD 3.83B 104M Sep/2026
Xeris Pharmaceuticals USD 76.92M 4M Sep/2026